✦ LIBER ✦

Characterization of Hepatitis C Virus genotype 3a Hypervariable region 1 in patients achieved rapid virological response to alpha interferon and Ribavirin Combination therapy

✍ Scribed by Madiha Akram; Muhammad Idrees; Abrar Hussain; Samia Afzal; Muhammad Ilyas; Shamail Zafar; Mahwish Aftab; Sadaf Badar; Bushra Khubaib

Book ID: 115022468
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 460 KB
Volume: 8
Category: Article
ISSN: 1743-422X
DOI: 10.1186/1743-422x-8-253

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of virological non-re

Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Eight-week regimen of antiviral combinat

Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Assessment of Hepatitis C Virus Protein

Assessment of Hepatitis C Virus Protein Sequences with Regard to Interferon/Ribavirin Combination Therapy Response in Patients with HCV Genotype 1b

✍ Sanja Glisic; Nevena Veljkovic; Snezana Jovanovic Cupic; Nada Vasiljevic; Jelena 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 344 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

Potent induction therapy with interferon

Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level

✍ Shotaro Enomoto; Hideyuki Tamai; Masashi Oka; Naoki Shingaki; Tatsuya Shiraki; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB